When juxtaposed with visual assessment, which is the prevailing benchmark in routine diagnostics, visible and near-infrared (Vis-NIR) hyperspectral imaging is dependable for ascertaining the percentage of PD-L1+ cells in human lymphoma through brightfield-based immunohistochemistry. This evidence concerns the gene CD274 and lymphoma.